Singular Bio
About:
Singular Bio is a privately held company developing single molecule detection technology.
Website: https://www.singularbio.com
Top Investors: Casdin Capital, Civilization Ventures
Description:
Singular Bio's technology provides single molecule analysis of a patient's DNA, giving exquisite sensitivity for detecting many common conditions. The company's mission is to expand access to fundamental healthcare information by making advanced genetic tests available to everyone.
Total Funding Amount:
$6.58M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2013-01-01
Founders:
Hywel Jones
Number of Employees:
11-50
Last Funding Date:
2019-01-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai